Biogen (BIIB) Tops Q1 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Biogen (BIIB) PT Raised to $280 at Stifel
April 25, 2017 11:18 AM EDTStifel analyst Thomas Shrader raised his price target on Biogen (NASDAQ: BIIB) to $280.00 (from $265.00) while maintaining a Hold rating following results this morning.
The analyst noted the results were positive for the companys goal to trim some of the fat from... More



